Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo

Yasunori Cho, Toshihiko Ueda, Atsuo Mori, Tsukasa Nakamichi, Hideyuki Shimizu, Yoshito Inoue, Shiaki Kawada

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background. Considerable evidence exists that neurotoxicity of excitatory amino acids is related to the neuronal injury, including paraplegia. However, little is known about aspartate neurotoxicity in the spinal cord in vivo. We evaluated the detrimental effects of exogenous aspartate on spinal cord neurons under metabolic stress. Methods. New Zealand white rabbits underwent an infrarenal aortic isolation. Group A animals (n = 7) received segmental aspartate 50 mmol/L) infusion for 10 minutes. Group B animals (n = 7) received saline as a negative control. Group C animals (n = 5) received segmental aspartate 100 mmol/L) infusion for 5 minutes. Group D animals (n = 7) were pretreated with segmental infusion of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptan-5,10-imine (MK-801) (6 mg/kg), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist for 1 minute, followed by segmental infusion of aspartate (50 mmol/L) for 9 minutes. Group E animals (n = 7) received vehicle only, followed by aspartate (50 mmol/L) infusion as a control of group D. Neurologic status was assessed at 12, 24, and 48 hours after operation using the Tarlov score. Results. Group A animals exhibited paraplegia or paraparesis with marked neuronal necrosis. Group B and C animals recovered fully. Group D animals showed significantly better neurologic function (p = 0.0007) compared with group E animals that exhibited paraplegia or paraparesis. Conclusions. Exogenous aspartate can have detrimental effects on spinal cord neurons under metabolic stress. This model may be useful in assaying neuronal injury mediated by NMDA receptor in vivo. (C) 2000 by The Society of Thoracic Surgeons.

Original languageEnglish
Pages (from-to)1496-1500
Number of pages5
JournalAnnals of Thoracic Surgery
Volume70
Issue number5
DOIs
Publication statusPublished - 2000

Fingerprint

Physiological Stress
Aspartic Acid
Spinal Cord
Paraplegia
Paraparesis
N-Methyl-D-Aspartate Receptors
Nervous System
Neurons
Excitatory Amino Acids
Imines
Dizocilpine Maleate
Wounds and Injuries
Necrosis
Rabbits
Control Groups

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo. / Cho, Yasunori; Ueda, Toshihiko; Mori, Atsuo; Nakamichi, Tsukasa; Shimizu, Hideyuki; Inoue, Yoshito; Kawada, Shiaki.

In: Annals of Thoracic Surgery, Vol. 70, No. 5, 2000, p. 1496-1500.

Research output: Contribution to journalArticle

Cho, Yasunori ; Ueda, Toshihiko ; Mori, Atsuo ; Nakamichi, Tsukasa ; Shimizu, Hideyuki ; Inoue, Yoshito ; Kawada, Shiaki. / Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo. In: Annals of Thoracic Surgery. 2000 ; Vol. 70, No. 5. pp. 1496-1500.
@article{1f2941f890d248c98af41e558309f208,
title = "Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo",
abstract = "Background. Considerable evidence exists that neurotoxicity of excitatory amino acids is related to the neuronal injury, including paraplegia. However, little is known about aspartate neurotoxicity in the spinal cord in vivo. We evaluated the detrimental effects of exogenous aspartate on spinal cord neurons under metabolic stress. Methods. New Zealand white rabbits underwent an infrarenal aortic isolation. Group A animals (n = 7) received segmental aspartate 50 mmol/L) infusion for 10 minutes. Group B animals (n = 7) received saline as a negative control. Group C animals (n = 5) received segmental aspartate 100 mmol/L) infusion for 5 minutes. Group D animals (n = 7) were pretreated with segmental infusion of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptan-5,10-imine (MK-801) (6 mg/kg), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist for 1 minute, followed by segmental infusion of aspartate (50 mmol/L) for 9 minutes. Group E animals (n = 7) received vehicle only, followed by aspartate (50 mmol/L) infusion as a control of group D. Neurologic status was assessed at 12, 24, and 48 hours after operation using the Tarlov score. Results. Group A animals exhibited paraplegia or paraparesis with marked neuronal necrosis. Group B and C animals recovered fully. Group D animals showed significantly better neurologic function (p = 0.0007) compared with group E animals that exhibited paraplegia or paraparesis. Conclusions. Exogenous aspartate can have detrimental effects on spinal cord neurons under metabolic stress. This model may be useful in assaying neuronal injury mediated by NMDA receptor in vivo. (C) 2000 by The Society of Thoracic Surgeons.",
author = "Yasunori Cho and Toshihiko Ueda and Atsuo Mori and Tsukasa Nakamichi and Hideyuki Shimizu and Yoshito Inoue and Shiaki Kawada",
year = "2000",
doi = "10.1016/S0003-4975(00)01835-X",
language = "English",
volume = "70",
pages = "1496--1500",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo

AU - Cho, Yasunori

AU - Ueda, Toshihiko

AU - Mori, Atsuo

AU - Nakamichi, Tsukasa

AU - Shimizu, Hideyuki

AU - Inoue, Yoshito

AU - Kawada, Shiaki

PY - 2000

Y1 - 2000

N2 - Background. Considerable evidence exists that neurotoxicity of excitatory amino acids is related to the neuronal injury, including paraplegia. However, little is known about aspartate neurotoxicity in the spinal cord in vivo. We evaluated the detrimental effects of exogenous aspartate on spinal cord neurons under metabolic stress. Methods. New Zealand white rabbits underwent an infrarenal aortic isolation. Group A animals (n = 7) received segmental aspartate 50 mmol/L) infusion for 10 minutes. Group B animals (n = 7) received saline as a negative control. Group C animals (n = 5) received segmental aspartate 100 mmol/L) infusion for 5 minutes. Group D animals (n = 7) were pretreated with segmental infusion of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptan-5,10-imine (MK-801) (6 mg/kg), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist for 1 minute, followed by segmental infusion of aspartate (50 mmol/L) for 9 minutes. Group E animals (n = 7) received vehicle only, followed by aspartate (50 mmol/L) infusion as a control of group D. Neurologic status was assessed at 12, 24, and 48 hours after operation using the Tarlov score. Results. Group A animals exhibited paraplegia or paraparesis with marked neuronal necrosis. Group B and C animals recovered fully. Group D animals showed significantly better neurologic function (p = 0.0007) compared with group E animals that exhibited paraplegia or paraparesis. Conclusions. Exogenous aspartate can have detrimental effects on spinal cord neurons under metabolic stress. This model may be useful in assaying neuronal injury mediated by NMDA receptor in vivo. (C) 2000 by The Society of Thoracic Surgeons.

AB - Background. Considerable evidence exists that neurotoxicity of excitatory amino acids is related to the neuronal injury, including paraplegia. However, little is known about aspartate neurotoxicity in the spinal cord in vivo. We evaluated the detrimental effects of exogenous aspartate on spinal cord neurons under metabolic stress. Methods. New Zealand white rabbits underwent an infrarenal aortic isolation. Group A animals (n = 7) received segmental aspartate 50 mmol/L) infusion for 10 minutes. Group B animals (n = 7) received saline as a negative control. Group C animals (n = 5) received segmental aspartate 100 mmol/L) infusion for 5 minutes. Group D animals (n = 7) were pretreated with segmental infusion of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptan-5,10-imine (MK-801) (6 mg/kg), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist for 1 minute, followed by segmental infusion of aspartate (50 mmol/L) for 9 minutes. Group E animals (n = 7) received vehicle only, followed by aspartate (50 mmol/L) infusion as a control of group D. Neurologic status was assessed at 12, 24, and 48 hours after operation using the Tarlov score. Results. Group A animals exhibited paraplegia or paraparesis with marked neuronal necrosis. Group B and C animals recovered fully. Group D animals showed significantly better neurologic function (p = 0.0007) compared with group E animals that exhibited paraplegia or paraparesis. Conclusions. Exogenous aspartate can have detrimental effects on spinal cord neurons under metabolic stress. This model may be useful in assaying neuronal injury mediated by NMDA receptor in vivo. (C) 2000 by The Society of Thoracic Surgeons.

UR - http://www.scopus.com/inward/record.url?scp=0033766691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033766691&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(00)01835-X

DO - 10.1016/S0003-4975(00)01835-X

M3 - Article

VL - 70

SP - 1496

EP - 1500

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -